4//SEC Filing
Bhowmick Neil 4
Accession 0001641172-25-002927
CIK 0001962011other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 8:30 AM ET
Size
5.1 KB
Accession
0001641172-25-002927
Insider Transaction Report
Form 4
Bhowmick Neil
Chief Scientific Officer
Transactions
- Award
COMMON STOCK
2025-01-01+14,000→ 1,139,983 total
Footnotes (2)
- [F1]Represents 14,000 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 14,000 RSUs are scheduled to vest in one third increments on each of 01/01/2025, 09/16/2025, and 09/16/2026. Accordingly, 4,667 RSUs have vested as of the date hereof.
- [F2]Consists of (1) 1,130,650 shares of common stock and (2) 9,333 RSUs which remain subject to vesting.
Documents
Issuer
Kairos Pharma, LTD.
CIK 0001962011
Entity typeother
Related Parties
1- filerCIK 0001872210
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 8:30 AM ET
- Size
- 5.1 KB